Raymond R Gaeta, MD
Anesthesiology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 8
Offices
8 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gaeta’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G60351 · Current
Licensed to practise in California · since 1987 · expires 2028-08-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$196,521
Medicare paid this office $196,521 for 730 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 610 | $144,657 | $106 |
| New patient visit (60+ min) | 140 | $26,186 | $187 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 423 | $8,889 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 76 | $8,049 | $65 |
| Short return visit (20+ min) | 56 | $6,866 | $80 |
Who their Medicare patients are
730 Original Medicare patients in 2024. Average age 71 · Under 65 21% · 85 and older 10% · Women 69% · Also on Medicaid 22% · Health risk score 1.35. At or below the middle of the specialty; the typical anesthesiology clinician is at 1.54.
Conditions among them: High blood pressure 65% · Depression 40% · Diabetes 23% · Chronic kidney disease 21% · Coronary heart disease 20% · Atrial fibrillation 18% · Heart failure 15% · COPD 14% · Cancer 12% · Dementia 5% · Stroke 5%.
The office billed $702,370, Medicare allowed $271,039 and paid $196,521; for 2,349 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 730 | 2,349 | 71 | 1.35 | $702,370 | $196,521 |
| 2023 | 716 | 1,606 | 71 | 1.38 | $551,066 | $168,649 |
| 2022 | 587 | 1,587 | 69 | 1.36 | $500,331 | $158,578 |
| 2021 | 658 | 1,565 | 69 | 1.40 | $419,098 | $146,889 |
| 2020 | 615 | 1,539 | 69 | 1.48 | $322,075 | $105,867 |
| 2019 | 515 | 1,373 | 68 | 1.50 | $400,849 | $108,918 |
| 2018 | 345 | 834 | 66 | 1.45 | $266,641 | $77,183 |
| 2017 | 68 | 115 | 65 | 1.29 | $44,819 | $13,024 |
| 2016 | 23 | 28 | 69 | 1.48 | $13,572 | $4,162 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 586 | $134,485 | $107 |
| New patient visit (60+ min) | 73 | $14,507 | $199 |
| Telephone medical discussion with physician, 11-20 minutes | 115 | $11,878 | $65 |
| Short return visit (20+ min) | 35 | $3,911 | $74 |
| New patient visit (45+ min) | 14 | $1,813 | $129 |
2022: 6 services
| Return visit (30+ min) | 416 | $108,245 | $112 |
| Short return visit (20+ min) | 153 | $14,991 | $68 |
| Telephone medical discussion with physician, 11-20 minutes | 126 | $13,060 | $60 |
| New patient visit (45+ min) | 90 | $10,202 | $113 |
| New patient visit (60+ min) | 38 | $7,720 | $203 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,127 | $89 |
2021: 9 services
| Return visit (30+ min) | 349 | $65,132 | $117 |
| Short return visit (20+ min) | 296 | $32,566 | $72 |
| Telephone medical discussion with physician, 11-20 minutes | 175 | $19,109 | $66 |
| New patient visit (45+ min) | 123 | $16,964 | $138 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $4,409 | $100 |
| New patient visit (30+ min) | 38 | $3,594 | $95 |
| Long return visit (40+ min) | 11 | $2,061 | $172 |
| Telephone medical discussion with physician, 5-10 minutes | 25 | $1,150 | $40 |
| Short return visit | 12 | $580 | $48 |
2020: 10 services
| Short return visit (20+ min) | 386 | $38,747 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 220 | $20,467 | $64 |
| New patient visit (30+ min) | 102 | $9,972 | $98 |
| Telephone medical discussion with physician, 21-30 minutes | 64 | $7,812 | $93 |
| Return visit (30+ min) | 67 | $7,416 | $83 |
| New patient visit (45+ min) | 52 | $7,413 | $143 |
| New patient visit (60+ min) | 38 | $5,815 | $153 |
| Telephone medical discussion with physician, 5-10 minutes | 107 | $5,173 | $38 |
| New patient visit (15+ min) | 22 | $1,468 | $67 |
| Short return visit | 19 | $758 | $40 |
2019: 6 services
| Short return visit (20+ min) | 381 | $56,892 | $60 |
| New patient visit (60+ min) | 105 | $17,222 | $164 |
| New patient visit (45+ min) | 97 | $13,453 | $139 |
| Return visit (30+ min) | 92 | $13,171 | $93 |
| New patient visit (30+ min) | 65 | $6,064 | $93 |
| Long return visit (40+ min) | 11 | $1,470 | $134 |
2018: 6 services
| Short return visit (20+ min) | 199 | $27,061 | $64 |
| New patient visit (60+ min) | 88 | $15,358 | $175 |
| New patient visit (45+ min) | 101 | $14,184 | $140 |
| Return visit (30+ min) | 84 | $11,879 | $95 |
| Long return visit (40+ min) | 33 | $4,074 | $120 |
| New patient visit (30+ min) | 37 | $3,404 | $92 |
2017: 4 services
| New patient visit (60+ min) | 40 | $6,653 | $166 |
| Short return visit (20+ min) | 20 | $2,284 | $63 |
| Long return visit (40+ min) | 17 | $2,124 | $125 |
| Return visit (30+ min) | 12 | $1,405 | $100 |
2016: 1 service
| New patient visit (60+ min) | 16 | $2,861 | $179 |
Medicaid work
$26,430 in 2024
Medicaid paid $26,430 for 463 billed services this clinician did in 2024, up to 45 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 411 | $26,309 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 52 | $121 |
| 2024 | 463 | 2 | 45 | $26,430 |
| 2023 | 561 | 1 | 58 | $25,376 |
| 2022 | 553 | 2 | 59 | $22,137 |
| 2021 | 408 | 2 | 42 | $12,932 |
| 2020 | 304 | 1 | 33 | $6,606 |
| 2019 | 314 | 1 | 32 | $7,530 |
| 2018 | 80 | 1 | 24 | $2,170 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 561 | $25,376 |
2022
| Return visit (30+ min) | 482 | $20,239 |
| Short return visit (20+ min) | 71 | $1,898 |
2021
| Short return visit (20+ min) | 222 | $6,645 |
| Return visit (30+ min) | 186 | $6,287 |
2020
| Short return visit (20+ min) | 304 | $6,606 |
2019
| Short return visit (20+ min) | 314 | $7,530 |
2018
| Short return visit (20+ min) | 80 | $2,170 |
Drugs they prescribed that Part D paid
$1,017,174
Pharmacies billed $1,017,174 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 66% of their Part D prescriptions (7,173 of 10,843) in 2024. A higher opioid share than 9 in 10 peers; the typical anesthesiology clinician is at 0%. Long-acting opioids: 32% of their opioid prescriptions.
9,739 generic and fewer than 11 brand-name prescriptions · $1,017,174 in drug cost · 90 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 1,195 | $291,221 | $244 |
| Belbuca | 230 | $193,039 | $839 |
| Oxycontin | 122 | $102,876 | $843 |
| Hydrocodone-Acetaminophen | 1,906 | $68,169 | $36 |
| Butrans | 105 | $40,095 | $382 |
See all 59 drugs
| Buprenorphine | None | 1,195 | $291,221 | $244 |
| Belbuca | None | 230 | $193,039 | $839 |
| Oxycontin | None | 122 | $102,876 | $843 |
| Hydrocodone-Acetaminophen | None | 1,906 | $68,169 | $36 |
| Butrans | None | 105 | $40,095 | $382 |
| Oxycodone-Acetaminophen | None | 748 | $32,948 | $44 |
| Buprenorphine | None | 721 | $29,319 | $41 |
| Oxycodone | None | 1,033 | $23,613 | $23 |
| Aimovig | Migraine | 11 | $14,884 | $1,353 |
| Xtampza Er | None | 20 | $13,901 | $695 |
| Pregabalin | None | 463 | $12,631 | $27 |
| Buprenorphine-Naloxone | None | 86 | $12,615 | $147 |
| Fentanyl | None | 98 | $11,851 | $121 |
| Hydromorphone | None | 615 | $9,943 | $16 |
| Morphine Sulfate Er | None | 250 | $6,933 | $28 |
| Gabapentin | None | 373 | $6,338 | $17 |
| Butalb-Acetaminoph-Caff-Codein | None | 30 | $6,174 | $206 |
| Morphine Sulfate | None | 163 | $5,711 | $35 |
| Cyclobenzaprine | None | 161 | $3,708 | $23 |
| Dantrolene | None | 66 | $3,462 | $52 |
| Butalbital-Acetaminophen-Caffe | None | 39 | $3,298 | $85 |
| Methadone | None | 194 | $3,213 | $17 |
| Tramadol | None | 321 | $3,018 | $9 |
| Naloxone | None | 45 | $2,764 | $61 |
| Baclofen | None | 116 | $2,735 | $24 |
| Duloxetine | None | 133 | $2,715 | $20 |
| Tramadol Hcl Er | None | 47 | $2,571 | $55 |
| Quetiapine | None | 145 | $2,304 | $16 |
| Tizanidine | None | 165 | $1,566 | $9 |
| Lidocaine | None | 25 | $1,414 | $57 |
| Acetaminophen-Codeine | None | 68 | $1,351 | $20 |
| Celecoxib | None | 67 | $1,337 | $20 |
| Levetiracetam | None | 45 | $1,220 | $27 |
| Trazodone | None | 61 | $1,076 | $18 |
| Bethanechol Chloride | None | 13 | $735 | $57 |
| Amitriptyline | None | 39 | $656 | $17 |
| Lamotrigine | None | 11 | $638 | $58 |
| Diclofenac | None | 18 | $614 | $34 |
| Ondansetron Odt | None | 42 | $613 | $15 |
| Methocarbamol | None | 47 | $578 | $12 |
| Nortriptyline | None | 19 | $425 | $22 |
| Zolpidem | None | 78 | $354 | $5 |
| Imipramine | None | 20 | $333 | $17 |
| Rizatriptan | None | 27 | $322 | $12 |
| Diazepam | None | 71 | $303 | $4 |
| Alprazolam | None | 19 | $301 | $16 |
| Lorazepam | None | 47 | $216 | $5 |
| Nabumetone | None | 12 | $208 | $17 |
| Sumatriptan | None | 14 | $207 | $15 |
| Ibuprofen | None | 34 | $206 | $6 |
| Lactulose | None | 27 | $191 | $7 |
| Promethazine | None | 19 | $175 | $9 |
| Paroxetine | None | 15 | $159 | $11 |
| Escitalopram | None | 24 | $155 | $6 |
| Carisoprodol | None | 23 | $122 | $5 |
| Ropinirole | None | 16 | $120 | $8 |
| Topiramate | None | 16 | $119 | $7 |
| Ondansetron | None | 19 | $104 | $5 |
| Hydroxyzine | None | 22 | $92 | $4 |
Year by year
| 2024 | 10,843 | 1,147 | 66% (7,173) | None | $1,017,174 |
| 2023 | 10,295 | 1,035 | 68% (6,973) | 13% | $1,306,091 |
| 2022 | 7,432 | 874 | 61% (4,564) | 15% | $971,422 |
| 2021 | 7,396 | 805 | 61% (4,505) | 17% | $974,561 |
| 2020 | 6,447 | 688 | 63% (4,047) | 18% | $897,659 |
| 2019 | 6,367 | 529 | 70% (4,484) | 24% | $975,067 |
| 2018 | 2,362 | 295 | 71% (1,668) | None | $376,094 |
| 2017 | 148 | 36 | 62% (91) | 35% | $26,043 |
| 2016 | 526 | 62 | 40% (208) | 10% | $39,816 |
| 2015 | 655 | 67 | 45% (297) | 10% | $58,489 |
| 2014 | 504 | 56 | 47% (238) | 18% | $60,080 |
| 2013 | 398 | 43 | 51% (201) | 17% | $35,258 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 62 drugs
| Buprenorphine | 1,121 | $395,589 | $353 |
| Belbuca | 200 | $164,604 | $823 |
| Oxycontin | 154 | $119,137 | $774 |
| Butrans | 144 | $115,573 | $803 |
| Hydrocodone-Acetaminophen | 1,748 | $68,206 | $39 |
| Oxycodone-Acetaminophen | 789 | $43,687 | $55 |
| Ubrelvy | 15 | $39,034 | $2,602 |
| Buprenorphine | 602 | $33,783 | $56 |
| Oxycodone | 947 | $26,086 | $28 |
| Buprenorphine-Naloxone | 111 | $22,817 | $206 |
| Movantik | 39 | $22,146 | $568 |
| Fentanyl | 138 | $19,240 | $139 |
| Pregabalin | 326 | $15,803 | $48 |
| Hydromorphone | 723 | $12,241 | $17 |
| Xtampza Er | 17 | $11,726 | $690 |
| Suboxone | 11 | $9,604 | $873 |
| Gabapentin | 381 | $9,508 | $25 |
| Morphine Sulfate Er | 225 | $7,019 | $31 |
| Dantrolene | 78 | $6,551 | $84 |
| Butalb-Acetaminoph-Caff-Codein | 37 | $5,894 | $159 |
| Morphine Sulfate | 131 | $5,477 | $42 |
| Tizanidine | 149 | $3,964 | $27 |
| Quetiapine | 128 | $3,646 | $28 |
| Duloxetine | 139 | $3,516 | $25 |
| Methadone | 189 | $3,515 | $19 |
| Naloxone | 41 | $3,413 | $83 |
| Tramadol | 295 | $3,409 | $12 |
| Cyclobenzaprine | 121 | $3,344 | $28 |
| Lidocaine | 30 | $3,156 | $105 |
| Butalbital-Acetaminophen-Caffe | 38 | $3,103 | $82 |
| Baclofen | 76 | $2,585 | $34 |
| Diclofenac | 43 | $2,261 | $53 |
| Ondansetron Odt | 53 | $1,515 | $29 |
| Acetaminophen-Codeine | 64 | $1,247 | $19 |
| Rizatriptan | 33 | $1,217 | $37 |
| Tramadol Hcl Er | 17 | $1,062 | $62 |
| Levetiracetam | 44 | $1,027 | $23 |
| Celecoxib | 54 | $1,011 | $19 |
| Bethanechol Chloride | 19 | $829 | $44 |
| Amitriptyline | 41 | $789 | $19 |
| Trazodone | 33 | $725 | $22 |
| Zolpidem | 58 | $655 | $11 |
| Ondansetron | 36 | $626 | $17 |
| Imipramine | 20 | $614 | $31 |
| Methocarbamol | 36 | $593 | $16 |
| Escitalopram | 27 | $525 | $19 |
| Nabumetone | 14 | $504 | $36 |
| Lorazepam | 41 | $495 | $12 |
| Nortriptyline | 19 | $472 | $25 |
| Lamotrigine | 17 | $384 | $23 |
| Topiramate | 17 | $365 | $21 |
| Lactulose | 16 | $352 | $22 |
| Carisoprodol | 24 | $304 | $13 |
| Diazepam | 66 | $269 | $4 |
| Paroxetine | 26 | $267 | $10 |
| Hydroxyzine | 20 | $256 | $13 |
| Propranolol | 13 | $232 | $18 |
| Meloxicam | 15 | $134 | $9 |
| Methylprednisolone | 14 | $119 | $9 |
| Promethazine | 20 | $58 | $3 |
| Fluoxetine | 13 | $44 | $3 |
| Clonidine | 11 | $43 | $4 |
2022: 62 drugs
| Buprenorphine | None | 920 | $322,269 | $350 |
| Belbuca | None | 139 | $110,303 | $794 |
| Butrans | None | 98 | $77,090 | $787 |
| Oxycontin | None | 92 | $72,044 | $783 |
| Hydrocodone-Acetaminophen | None | 1,165 | $45,437 | $39 |
| Ubrelvy | None | 22 | $43,494 | $1,977 |
| Buprenorphine | None | 501 | $26,921 | $54 |
| Oxycodone-Acetaminophen | None | 498 | $25,673 | $52 |
| Oxycodone | None | 549 | $17,580 | $32 |
| Aimovig | Migraine | 13 | $17,162 | $1,320 |
| Emgality | Migraine | 13 | $14,759 | $1,135 |
| Pregabalin | None | 252 | $11,364 | $45 |
| Fentanyl | None | 96 | $11,047 | $115 |
| Buprenorphine-Naloxone | None | 49 | $11,044 | $225 |
| Gabapentin | None | 393 | $10,106 | $26 |
| Suboxone | None | 11 | $9,606 | $873 |
| Xtampza Er | None | 19 | $9,004 | $474 |
| Duloxetine | None | 210 | $8,338 | $40 |
| Butalb-Acetaminoph-Caff-Codein | None | 28 | $6,559 | $234 |
| Movantik | None | 13 | $6,242 | $480 |
| Hydromorphone | None | 365 | $6,108 | $17 |
| Baclofen | None | 89 | $5,088 | $57 |
| Morphine Sulfate Er | None | 130 | $4,799 | $37 |
| Quetiapine | None | 114 | $4,757 | $42 |
| Oxycodone Hcl Er | None | 11 | $4,667 | $424 |
| Celecoxib | None | 56 | $4,352 | $78 |
| Dantrolene | None | 43 | $3,476 | $81 |
| Tizanidine | None | 132 | $3,447 | $26 |
| Lubiprostone | None | 13 | $3,196 | $246 |
| Lidocaine | None | 26 | $3,004 | $116 |
| Cyclobenzaprine | None | 114 | $2,814 | $25 |
| Morphine Sulfate | None | 67 | $2,362 | $35 |
| Methadone | None | 123 | $2,314 | $19 |
| Butalbital-Acetaminophen-Caffe | None | 23 | $2,232 | $97 |
| Diclofenac | None | 35 | $1,877 | $54 |
| Tramadol | None | 197 | $1,776 | $9 |
| Naloxone | None | 18 | $1,624 | $90 |
| Trazodone | None | 53 | $1,457 | $27 |
| Ondansetron Odt | None | 43 | $1,439 | $33 |
| Ondansetron | None | 32 | $1,294 | $40 |
| Acetaminophen-Codeine | None | 38 | $1,083 | $28 |
| Amitriptyline | None | 29 | $951 | $33 |
| Methocarbamol | None | 25 | $681 | $27 |
| Rizatriptan | None | 25 | $527 | $21 |
| Bethanechol Chloride | None | 14 | $491 | $35 |
| Levetiracetam | None | 20 | $487 | $24 |
| Imipramine | None | 15 | $463 | $31 |
| Zolpidem | None | 35 | $384 | $11 |
| Ropinirole | None | 13 | $362 | $28 |
| Lactulose | None | 17 | $345 | $20 |
| Nortriptyline | None | 16 | $330 | $21 |
| Naltrexone | None | 12 | $299 | $25 |
| Escitalopram | None | 19 | $284 | $15 |
| Fluticasone Propionate | None | 11 | $284 | $26 |
| Paroxetine | None | 21 | $207 | $10 |
| Alprazolam | None | 11 | $201 | $18 |
| Diazepam | None | 39 | $163 | $4 |
| Clonidine | None | 22 | $154 | $7 |
| Ibuprofen | None | 11 | $119 | $11 |
| Methylprednisolone | None | 12 | $105 | $9 |
| Lorazepam | None | 18 | $100 | $6 |
| Levothyroxine | None | 12 | $69 | $6 |
2021: 58 drugs
| Buprenorphine | None | 937 | $323,969 | $346 |
| Belbuca | None | 198 | $146,042 | $738 |
| Butrans | None | 147 | $100,339 | $683 |
| Hydrocodone-Acetaminophen | None | 1,042 | $42,973 | $41 |
| Percocet | None | 14 | $30,017 | $2,144 |
| Buprenorphine | None | 521 | $28,624 | $55 |
| Oxycontin | None | 71 | $27,070 | $381 |
| Oxycodone-Acetaminophen | None | 477 | $21,602 | $45 |
| Ubrelvy | None | 18 | $19,952 | $1,108 |
| Oxycodone | None | 547 | $18,508 | $34 |
| Aimovig | Migraine | 21 | $15,022 | $715 |
| Pregabalin | None | 257 | $14,097 | $55 |
| Xtampza Er | None | 25 | $13,021 | $521 |
| Buprenorphine-Naloxone | None | 43 | $11,416 | $265 |
| Gabapentin | None | 421 | $9,628 | $23 |
| Fentanyl | None | 88 | $7,790 | $89 |
| Hydromorphone | None | 306 | $7,613 | $25 |
| Butalb-Acetaminoph-Caff-Codein | None | 20 | $6,527 | $326 |
| Baclofen | None | 116 | $6,519 | $56 |
| Tizanidine | None | 188 | $5,770 | $31 |
| Duloxetine | None | 187 | $5,592 | $30 |
| Morphine Sulfate Er | None | 133 | $4,324 | $33 |
| Lubiprostone | None | 12 | $2,912 | $243 |
| Acetaminophen-Codeine | None | 39 | $2,640 | $68 |
| Methadone | None | 135 | $2,539 | $19 |
| Narcan | None | 19 | $2,473 | $130 |
| Tramadol | None | 210 | $2,127 | $10 |
| Quetiapine | None | 68 | $2,117 | $31 |
| Morphine Sulfate | None | 54 | $2,036 | $38 |
| Celecoxib | None | 44 | $1,825 | $41 |
| Cyclobenzaprine | None | 91 | $1,695 | $19 |
| Ondansetron | None | 51 | $1,666 | $33 |
| Lidocaine | None | 11 | $1,645 | $150 |
| Amitriptyline | None | 49 | $1,637 | $33 |
| Hydrocodone-Ibuprofen | None | 12 | $1,496 | $125 |
| Butalbital-Acetaminophen-Caffe | None | 20 | $1,467 | $73 |
| Levetiracetam | None | 21 | $1,263 | $60 |
| Diclofenac | None | 28 | $1,242 | $44 |
| Trazodone | None | 53 | $1,198 | $23 |
| Rizatriptan | None | 40 | $1,110 | $28 |
| Ondansetron Odt | None | 26 | $697 | $27 |
| Nortriptyline | None | 29 | $684 | $24 |
| Lactulose | None | 19 | $654 | $34 |
| Topiramate | None | 20 | $498 | $25 |
| Escitalopram | None | 16 | $346 | $22 |
| Mirtazapine | None | 18 | $334 | $19 |
| Alprazolam | None | 18 | $272 | $15 |
| Diazepam | None | 49 | $269 | $5 |
| Ibuprofen | None | 20 | $258 | $13 |
| Naproxen | None | 21 | $256 | $12 |
| Lamotrigine | None | 12 | $236 | $20 |
| Lorazepam | None | 34 | $218 | $6 |
| Zolpidem | None | 36 | $198 | $6 |
| Paroxetine | None | 12 | $144 | $12 |
| Imipramine | None | 16 | $144 | $9 |
| Promethazine | None | 11 | $134 | $12 |
| Methocarbamol | None | 18 | $133 | $7 |
| Sertraline | None | 16 | $32 | $2 |
2020: 54 drugs
| Buprenorphine | None | 840 | $299,462 | $357 |
| Belbuca | None | 241 | $152,750 | $634 |
| Butrans | None | 205 | $133,057 | $649 |
| Hydrocodone-Acetaminophen | None | 901 | $31,527 | $35 |
| Buprenorphine | None | 465 | $30,285 | $65 |
| Oxycontin | None | 81 | $28,814 | $356 |
| Aimovig | Migraine | 40 | $25,438 | $636 |
| Oxycodone-Acetaminophen | None | 395 | $20,496 | $52 |
| Percocet | None | 13 | $17,853 | $1,373 |
| Oxycodone | None | 486 | $15,496 | $32 |
| Pregabalin | None | 222 | $10,980 | $49 |
| Emgality | Migraine | 12 | $10,506 | $875 |
| Buprenorphine-Naloxone | None | 32 | $9,536 | $298 |
| Xtampza Er | None | 20 | $8,076 | $404 |
| Gabapentin | None | 306 | $5,811 | $19 |
| Oxycodone Hcl Er | None | 13 | $5,237 | $403 |
| Tizanidine | None | 197 | $5,107 | $26 |
| Morphine Sulfate Er | None | 150 | $4,876 | $33 |
| Butalb-Acetaminoph-Caff-Codein | None | 13 | $4,867 | $374 |
| Duloxetine | None | 173 | $4,612 | $27 |
| Hydromorphone | None | 213 | $4,535 | $21 |
| Fentanyl | None | 61 | $3,556 | $58 |
| Ascomp With Codeine | None | 18 | $3,549 | $197 |
| Amitiza | None | 12 | $3,458 | $288 |
| Baclofen | None | 81 | $2,981 | $37 |
| Methadone | None | 158 | $2,788 | $18 |
| Narcan | None | 15 | $1,961 | $131 |
| Diclofenac | None | 49 | $1,903 | $39 |
| Trazodone | None | 78 | $1,783 | $23 |
| Morphine Sulfate | None | 32 | $1,578 | $49 |
| Tramadol | None | 155 | $1,523 | $10 |
| Celecoxib | None | 23 | $1,391 | $60 |
| Ondansetron | None | 30 | $1,034 | $34 |
| Amitriptyline | None | 39 | $963 | $25 |
| Topiramate | None | 30 | $920 | $31 |
| Cyclobenzaprine | None | 45 | $844 | $19 |
| Acetaminophen-Codeine | None | 27 | $788 | $29 |
| Rizatriptan | None | 16 | $722 | $45 |
| Quetiapine | None | 45 | $530 | $12 |
| Levetiracetam | None | 15 | $405 | $27 |
| Mirtazapine | None | 11 | $400 | $36 |
| Lactulose | None | 13 | $335 | $26 |
| Lamotrigine | None | 11 | $315 | $29 |
| Nortriptyline | None | 26 | $303 | $12 |
| Ondansetron Odt | None | 11 | $300 | $27 |
| Diazepam | None | 44 | $295 | $7 |
| Fluticasone Propionate | None | 14 | $266 | $19 |
| Methocarbamol | None | 14 | $189 | $13 |
| Naproxen | None | 16 | $186 | $12 |
| Zolpidem | None | 31 | $169 | $5 |
| Alprazolam | None | 13 | $143 | $11 |
| Sertraline | None | 18 | $122 | $7 |
| Imipramine | None | 19 | $122 | $6 |
| Lorazepam | None | 19 | $55 | $3 |
2019: 50 drugs
| Buprenorphine | 1,054 | $378,091 | $359 |
| Butrans | 271 | $154,463 | $570 |
| Belbuca | 235 | $127,530 | $543 |
| Lyrica | 83 | $51,791 | $624 |
| Oxycontin | 131 | $50,633 | $387 |
| Hydrocodone-Acetaminophen | 953 | $32,036 | $34 |
| Buprenorphine | 430 | $27,582 | $64 |
| Oxycodone-Acetaminophen | 440 | $19,848 | $45 |
| Oxycodone | 568 | $19,742 | $35 |
| Narcan | 92 | $11,845 | $129 |
| Suboxone | 12 | $7,682 | $640 |
| Morphine Sulfate Er | 200 | $6,815 | $34 |
| Fentanyl | 99 | $6,649 | $67 |
| Butalb-Caff-Acetaminoph-Codein | 11 | $4,139 | $376 |
| Duloxetine | 132 | $4,015 | $30 |
| Pregabalin | 54 | $3,908 | $72 |
| Hydromorphone | 151 | $3,894 | $26 |
| Xtampza Er | 13 | $3,722 | $286 |
| Buprenorphine-Naloxone | 19 | $3,624 | $191 |
| Morphine Sulfate | 37 | $3,492 | $94 |
| Gabapentin | 149 | $3,256 | $22 |
| Tizanidine | 185 | $2,906 | $16 |
| Clonidine | 15 | $2,902 | $193 |
| Methadone | 136 | $2,052 | $15 |
| Mexiletine | 13 | $1,814 | $140 |
| Butalbital-Aspirin-Caffeine | 12 | $1,528 | $127 |
| Tramadol | 103 | $1,308 | $13 |
| Baclofen | 70 | $1,269 | $18 |
| Topiramate | 25 | $1,251 | $50 |
| Acetaminophen-Codeine | 37 | $1,069 | $29 |
| Ascomp With Codeine | 14 | $1,034 | $74 |
| Diclofenac | 16 | $912 | $57 |
| Celecoxib | 29 | $731 | $25 |
| Trazodone | 48 | $572 | $12 |
| Cyclobenzaprine | 37 | $464 | $13 |
| Ondansetron | 41 | $455 | $11 |
| Clonazepam | 19 | $356 | $19 |
| Imipramine | 24 | $292 | $12 |
| Diazepam | 33 | $270 | $8 |
| Lactulose | 21 | $248 | $12 |
| Nortriptyline | 24 | $219 | $9 |
| Naproxen | 19 | $181 | $10 |
| Clonidine | 12 | $151 | $13 |
| Lorazepam | 19 | $144 | $8 |
| Zolpidem | 28 | $134 | $5 |
| Paroxetine | 12 | $121 | $10 |
| Quetiapine | 13 | $112 | $9 |
| Ropinirole | 16 | $110 | $7 |
| Alprazolam | 11 | $88 | $8 |
| Carisoprodol | 12 | $78 | $6 |
2018: 29 drugs
| Buprenorphine | 362 | $128,600 | $355 |
| Butrans | 190 | $97,276 | $512 |
| Oxycontin | 53 | $25,541 | $482 |
| Lyrica | 43 | $21,273 | $495 |
| Belbuca | 36 | $18,953 | $526 |
| Suboxone | 25 | $15,320 | $613 |
| Buprenorphine | 188 | $12,411 | $66 |
| Oxycodone | 251 | $10,477 | $42 |
| Hydrocodone-Acetaminophen | 309 | $9,032 | $29 |
| Fentanyl | 61 | $5,624 | $92 |
| Oxycodone-Acetaminophen | 108 | $5,133 | $48 |
| Morphine Sulfate Er | 82 | $3,459 | $42 |
| Lidocaine | 12 | $2,507 | $209 |
| Clonidine | 16 | $2,154 | $135 |
| Duloxetine | 44 | $1,365 | $31 |
| Tizanidine | 63 | $1,226 | $19 |
| Hydromorphone | 76 | $1,213 | $16 |
| Morphine Sulfate | 24 | $665 | $28 |
| Methadone | 47 | $618 | $13 |
| Tramadol | 46 | $594 | $13 |
| Gabapentin | 29 | $569 | $20 |
| Topiramate | 26 | $463 | $18 |
| Amitriptyline | 26 | $343 | $13 |
| Baclofen | 23 | $311 | $14 |
| Ondansetron | 24 | $213 | $9 |
| Diazepam | 22 | $196 | $9 |
| Cyclobenzaprine | 15 | $126 | $8 |
| Zolpidem | 13 | $105 | $8 |
| Acetaminophen-Codeine | 12 | $59 | $5 |
2017: 3 drugs
| Buprenorphine | 18 | $5,499 | $306 |
| Butrans | 14 | $4,732 | $338 |
| Butalb-Caff-Acetaminoph-Codein | 13 | $4,464 | $343 |
2016: 15 drugs
| Oxycontin | 14 | $19,005 | $1,357 |
| Hydrocodone-Acetaminophen | 114 | $6,376 | $56 |
| Butalb-Caff-Acetaminoph-Codein | 14 | $4,291 | $307 |
| Oxycodone | 13 | $801 | $62 |
| Gabapentin | 25 | $511 | $20 |
| Zolpidem | 39 | $464 | $12 |
| Baclofen | 25 | $430 | $17 |
| Methadone | 20 | $400 | $20 |
| Bupropion | 13 | $347 | $27 |
| Nortriptyline | 19 | $228 | $12 |
| Dextroamphetamine-Amphetamine | 15 | $183 | $12 |
| Omeprazole | 25 | $182 | $7 |
| Diazepam | 16 | $154 | $10 |
| Escitalopram | 11 | $64 | $6 |
| Amitriptyline | 11 | $61 | $6 |
2015: 18 drugs
| Oxycontin | 26 | $32,099 | $1,235 |
| Hydrocodone-Acetaminophen | 183 | $8,585 | $47 |
| Lyrica | 15 | $5,028 | $335 |
| Oxycodone-Acetaminophen | 11 | $1,399 | $127 |
| Morphine Sulfate Er | 13 | $1,219 | $94 |
| Duloxetine | 17 | $1,021 | $60 |
| Oxycodone | 15 | $798 | $53 |
| Baclofen | 27 | $769 | $28 |
| Zolpidem | 43 | $604 | $14 |
| Gabapentin | 22 | $474 | $22 |
| Bupropion | 12 | $339 | $28 |
| Omeprazole | 37 | $259 | $7 |
| Acetaminophen-Codeine | 12 | $255 | $21 |
| Naproxen | 35 | $212 | $6 |
| Amitriptyline | 28 | $206 | $7 |
| Tramadol | 19 | $158 | $8 |
| Hydromorphone | 11 | $137 | $12 |
| Escitalopram | 13 | $92 | $7 |
2014: 15 drugs
| Oxycontin | 26 | $30,062 | $1,156 |
| Lamictal | 13 | $6,482 | $499 |
| Hydrocodone-Acetaminophen | 114 | $4,136 | $36 |
| Duloxetine | 23 | $3,537 | $154 |
| Lyrica | 13 | $3,364 | $259 |
| Morphine Sulfate Er | 20 | $2,423 | $121 |
| Oxycodone | 17 | $1,072 | $63 |
| Baclofen | 22 | $364 | $17 |
| Methadone | 32 | $271 | $8 |
| Amitriptyline | 25 | $217 | $9 |
| Zolpidem | 28 | $180 | $6 |
| Escitalopram | 13 | $122 | $9 |
| Naproxen | 14 | $116 | $8 |
| Mirtazapine | 11 | $85 | $8 |
| Omeprazole | 11 | $82 | $7 |
2013: 14 drugs
| Oxycontin | 21 | $19,675 | $937 |
| Lyrica | 16 | $3,597 | $225 |
| Hydrocodone-Acetaminophen | 99 | $2,805 | $28 |
| Gabapentin | 14 | $1,514 | $108 |
| Butalb-Caff-Acetaminoph-Codein | 11 | $1,068 | $97 |
| Oxycodone | 20 | $855 | $43 |
| Morphine Sulfate Er | 12 | $566 | $47 |
| Hydromorphone | 12 | $299 | $25 |
| Baclofen | 29 | $290 | $10 |
| Naproxen | 19 | $141 | $7 |
| Zolpidem | 16 | $74 | $5 |
| Methadone | 11 | $66 | $6 |
| Clonazepam | 13 | $66 | $5 |
| Amitriptyline | 11 | $46 | $4 |
Money from drug and device companies
$49 in 2024
A payment is not proof that care is biased.
| Abiomed | Impella | $49 | 2 payments
|
See all 2 published payments
| Abiomed | Meals · 2024-09-19 | Impella | $18 |
| Abiomed | Meals · 2024-08-07 | Impella | $31 |
Professional record
- NPI
- 1225179823
- Licence
- CA G60351California G60351: Current · expires 2028-08-31
- Trained
- Stanford University School of Medicine, 1985
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G603510
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X)
- Mailing address
- 1900 Ofarrell St, Ste 100, San Mateo, CA, 94403
- NPI first listed
- 2007-02-08
- NPI last updated
- 2015-01-12
This is when the NPI record was last certified, not a medical board exam.